For the in vitro experiments, activated T cells were cocultured with HCC cells pretreated with or without AGK2 or aspirin or relatlimab, an anti–LAG-3 mAb (Supplemental Figure 5F). Here, LAG3 is linked to hepatocellular carcinoma.